PFO Closure for Migraine: Debates Continue as PREMIUM Published

Share this post

Patient subgroups may benefit, suggest some findings from the sham-controlled trial, at least the third major study of the controversial procedure. Further studies are warranted, says an observer.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply